02841nas a2200433 4500000000100000008004100001653001500042653001300057653001800070653000900088653003600097653003700133653002000170100001900190700001500209700001100224700001700235700001700252700001300269700001300282700001300295700001400308700001100322700001400333700001300347700001400360700001300374700001100387700001200398700001600410700001300426700001400439700003700453245014800490856008500638300000800723520166200731022001402393 2017 d10aTrichiasis10aTrachoma10aSAFE Strategy10aNTDs10aGlobal Trachoma Mapping Project10aDemocratic Republic of the Congo10aBaseline survey1 aKilangalanga J1 aNdjemba JM1 aUvon P1 aKibangala FM1 aMwandulo JSB1 aMavula N1 aNdombe M1 aKazadi J1 aLimbaka H1 aCohn D1 aTougoue J1 aKabore A1 aRotondo L1 aWillis R1 aBio AA1 aKadri B1 aBakhtiari A1 aNgondi J1 aSolomon A1 aGlobal Trachoma Mapping Project 00aTrachoma in the Democratic Republic of the Congo: Results of 46 baseline prevalence surveys conducted with the Global Trachoma Mapping Project. uhttp://www.tandfonline.com/doi/pdf/10.1080/09286586.2017.1306869?needAccess=true a1-93 a

PURPOSE: Trachoma was suspected to be endemic in parts of the Democratic Republic of the Congo (DRC). We aimed to estimate prevalences of trachomatous inflammation-follicular (TF), trichiasis, and water and sanitation (WASH) indicators in suspected-endemic Health Zones.

METHODS: A population-based prevalence survey was undertaken in each of 46 Health Zones across nine provinces of DRC, using Global Trachoma Mapping Project methods. A two-stage cluster random sampling design was used in each Health Zone, whereby 25 villages (clusters) and 30 households per cluster were sampled. Consenting eligible participants (children aged 1-9 years and adults aged ≥15 years) were examined for trachoma by GTMP-certified graders; households were assessed for access to WASH.

RESULTS: A total of 32,758 households were surveyed, and 141,853 participants (98.2% of those enumerated) were examined for trachoma. Health Zone-level TF prevalence in 1-9-year-olds ranged from 1.9-41.6%. Among people aged ≥15 years, trichiasis prevalences ranged from 0.02-5.1% (95% CI 3.3-6.8). TF prevalence in 1-9-year-olds was ≥5% in 30 Health Zones, while trichiasis prevalence was ≥0.2% in 37 Health Zones.

CONCLUSION: Trachoma is a public health problem in 39 of 46 Health Zones surveyed. To meet elimination targets, 37 Health Zones require expanded trichiasis surgery services while 30 health zones require antibiotics, facial cleanliness and environmental improvement interventions. Survey data suggest that trachoma is widespread: further surveys are warranted.

 a1744-5086